[1]
|
World Health Organization, Joint United Nations Programe on HIV/AIDS, “The Treatment 2.0 Framework for Action: Catalysing the Next Phase of Treatment, Care and Support,” Geneva, 2011.
|
[2]
|
G. Hirnschall and B. Schwartlander, “Treatment 2.0: Catalysing the Next Phase of Scale-Up,” The Lancet, Vol. 378, No. 9787, 2011, pp. 209-211.
doi:10.1016/S0140-6736(11)60247-X
|
[3]
|
B. Schwartlander, J. Stover, T. Hallett, R. Atun, C. Avila, E. Gouws, et al., “Towards an Improved Investment Approach for an Effective Response to HIV/AIDS,” The Lancet, Vol. 377, 9782, 2011, pp. 2031-2041.
doi:10.1016/S0140-6736(11)60702-2
|
[4]
|
World Health Organization, et al., “Global Health Sector Strategy on HIV/AIDS 2011-2015,” Geneva, 2011.
|
[5]
|
Joint United Nations Programme on HIV/AIDS, “UNAIDS 2011-2015 Strategy: Getting to Zero,” Geneva, 2010.
|
[6]
|
World Health Organization, “WHO HIV Strategy: Implementing Treatment 2.0, Side Event at the Sixty-Fourth World Health Assembly,” Geneva, 2011.
|
[7]
|
Joint United Nations Programme on HIV/AIDS, World Health Organization, “Vietnam Leads on Treatment 2.0—First Pilot Begins in Mid-2011,” Hanoi, 2011.
|
[8]
|
Ministry of Health, “20 Years: Responding to HIV/AIDS in Vietnam,” Hanoi, 2010.
|
[9]
|
L. Maher, H. Coupland and R. Musson, “Scaling up HIV Treatment, Care and Support for Injecting Drug Users in Vietnam,” International Journal of Drug Policy, Vol. 18, No. 4, 2007, pp. 296-305.
doi:10.1016/j.drugpo.2006.12.006
|
[10]
|
V. Van Tam, A. Pharris, A. Thorson, T. Alfven and M. Larsson, “It Is Not that I Forget, It’s just that I don’t Want Other People to Know: Barriers to and Strategies for Adherence to Antiretroviral Therapy among HIV Patients in Northern Vietnam,” AIDS Care, Vol. 23, No. 2, 2011, pp. 139-145. doi:10.1080/09540121.2010.507741
|
[11]
|
A. D. Ngo, E. A. Ratliff, S. A. McCurdy, M. W. Ross, C. Markham and H. T. Pham, “Health-seeking Behaviour for Sexually Transmitted Infections and HIV Testing among Female Sex Workers in Vietnam,” AIDS Care, Vol. 19, No. 7, 2007, pp. 878-887.
doi:10.1080/09540120601163078
|
[12]
|
World Health Organization, “Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach,” Geneva, 2010.
|
[13]
|
Vietnam Administration of HIV/AIDS Control, Pasteur Institute of Ho Chi Minh City, “Organization WH. Preliminary Results of HIV/AIDS Care and Treatment and Early Warning Indicators of HIV Drug Resistance, Southern Vietnam, 2010,” Ho Chi Minh City, 2011.
|
[14]
|
R. Subbaraman, S. K. Chaguturu, K. H. Mayer, T. P. Flanigan and N. Kumarasamy, “Adverse Effects of Highly Active Antiretroviral Therapy in Developing Countries,” Clinical Infectious Diseases, Vol. 45, No. 8, 2007, pp. 1093-1101. doi:10.1086/521150
|
[15]
|
G. McComsey and J. T. Lonergan, “Mitochondrial dysfunction: Patient Monitoring and Toxicity Management,” Journal of Acquired Immune Deficiency Syndromes, Vol. 37, Suppl. 1, 2004, pp. S30-S35.
doi:10.1097/01.qai.0000137004.63376.27
|
[16]
|
T. A. Nguyen, H. T. Nguyen, G. T. Le and R. Detels, “Prevalence and Risk Factors Associated with HIV Infection among Men Having Sex with Men in Ho Chi Minh City, Vietnam,” AIDS and Behavior, Vol. 12, No. 3, 2008, pp. 476-482. doi:10.1007/s10461-007-9267-y
|
[17]
|
V. F. Go, C. Frangakis, L. Van Nam, T. Sripaipan, A. Bergenstrom, F. Li, et al., “Characteristics of High-Risk HIV-Positive IDUs in Vietnam: Implications for Future Interventions,” Substance Use & Misuse, Vol. 46, No. 4, 2011, pp. 381-389. doi:10.3109/10826084.2010.505147
|
[18]
|
M. S. Cohen, Y. Q. Chen, M. McCauley, T. Gamble, M. C. Hosseinipour, N. Kumarasamy, et al., “Prevention of HIV-1 Infection with Early Antiretroviral Therapy,” The New England Journal of Medicine, Vol. 365, No. 6, 2011, pp. 493-505. doi:10.1056/NEJMoa1105243
|